Methamphetamine is a potent psychostimulant that can induce psychosis among
recreational and chronic users, with some users developing a persistent psychotic syndrome …

During the past 18 months, studies have been published that cover risk factors, neuronal
mechanisms, and treatment. These recent results do not differ from previous …

Aim Methamphetamine use is a new health concern in Iran, the most populated Persian Gulf
country. However, there is no well-documented literature. The current study objectives were …

Longitudinal studies of substance-induced psychosis (SIP) suggest that approximately 11–
46% of persons will progress to schizophrenia with differential risk of progression depending …

In substance use and addiction, inhibitory control is key to ignoring triggers, withstanding
craving and maintaining abstinence. In amphetamine-type stimulant (ATS) users, most …

Methamphetamine (hereafter, meth) addiction results in various emotional problems linked
to structural impairments in the prefrontal cortex (PFC). In this paper, we investigated …

Background Currently, few studies have examined the mental states of Women
methamphetamine patients, and the influence of impulsivity and perceived social support on …

Background The clinical profiles of methamphetamine-induced psychosis (MIP) and
schizophrenia are largely overlapping making differentiation challenging. In this systematic …

The evaluation and management of methamphetamine-associated psychosis (MAP) is an
area of study with a paucity of large-scale, longitudinal data. Methamphetamine use has …

Psychotic disorders, such as schizophrenia, are characterized by prevalent and persistent
executive deficits that are believed to be the result of dysfunctional inhibitory gamma …